• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    New insider Pickett Jason Marc claimed ownership of 40,113 shares (SEC Form 3)

    4/29/25 3:45:04 PM ET
    $AVNS
    Industrial Specialties
    Health Care
    Get the next $AVNS alert in real time by email
    SEC FORM 3 SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    Pickett Jason Marc

    (Last) (First) (Middle)
    5405 WINDWARD PARKWAY

    (Street)
    ALPHARETTA GA 30004

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    04/14/2025
    3. Issuer Name and Ticker or Trading Symbol
    AVANOS MEDICAL, INC. [ AVNS ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    Interim CFO and Treasurer
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Common Stock 40,113(1) D
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    Employee Stock Option (right to buy) (2) 05/05/2026 Common Stock 1,174 $29.48 D
    Employee Stock Option (right to buy) (3) 05/03/2027 Common Stock 1,670 $36.74 D
    Employee Stock Option (right to buy) (4) 05/03/2028 Common Stock 1,278 $52.1 D
    Employee Stock Option (right to buy) (5) 05/08/2029 Common Stock 1,509 $43.59 D
    Employee Stock Option (right to buy) (6) 05/07/2030 Common Stock 3,182 $28.87 D
    Explanation of Responses:
    1. Of these shares, 28,476 are represented by time-based restricted share units (TRSUs) awarded pursuant to the Issuer's 2021 Long Term Incentive Plan, as amended. These TRSUs will vest as follows: (i) 16,300 on April 22, 2026; (ii) 2,496 on May 6, 2026; (iii) 1,510 on May 6, 2027; (iv) 2,696 on May 7, 2026; (v) 2,696 on May 7, 2027; and (vi) 2,778 on May 7, 2028. Each TRSU is the economic equivalent of one share of Common Stock.
    2. These options vested 30% on May 5, 2017, 30% on May 5, 2018, and 40% on May 5, 2019.
    3. These options vested 30% on May 3, 2018, 30% on May 3, 2019, and 40% on May 3, 2020.
    4. These options vested 30% on May 3, 2019, 30% on May 3, 2020, and 40% on May 3, 2021.
    5. These options vested 30% on May 8, 2020, 30% on May 8, 2021, and 40% on May 8, 2022.
    6. These options vested 30% on May 7, 2021, 30% on May 7, 2022, and 40% on May 7, 2023.
    Remarks:
    /s/ Mojirade James, as attorney-in-fact for Jason Pickett pursuant to Power of Attorney filed herewith 04/29/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $AVNS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AVNS

    DatePrice TargetRatingAnalyst
    7/25/2023Overweight → Sector Weight
    KeyBanc Capital Markets
    5/22/2023$31.00Buy
    CL King
    2/24/2022$47.00 → $41.00Overweight
    Keybanc
    1/7/2022$37.00 → $36.00Underweight
    Morgan Stanley
    8/4/2021$45.00 → $41.00Underweight
    Morgan Stanley
    8/4/2021$60.00 → $45.00Overweight → Equal-Weight
    Stephens
    8/4/2021$55.00 → $47.00Overweight
    Keybanc
    More analyst ratings

    $AVNS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Shimer Julie Ann bought $9,925 worth of shares (500 units at $19.85), increasing direct ownership by 1% to 50,090 units (SEC Form 4)

      4 - AVANOS MEDICAL, INC. (0001606498) (Issuer)

      3/11/24 5:15:37 PM ET
      $AVNS
      Industrial Specialties
      Health Care

    $AVNS
    SEC Filings

    See more
    • SEC Form S-8 filed by Avanos Medical Inc.

      S-8 - AVANOS MEDICAL, INC. (0001606498) (Filer)

      6/18/25 3:41:51 PM ET
      $AVNS
      Industrial Specialties
      Health Care
    • SEC Form SD filed by Avanos Medical Inc.

      SD - AVANOS MEDICAL, INC. (0001606498) (Filer)

      6/2/25 11:36:00 AM ET
      $AVNS
      Industrial Specialties
      Health Care
    • SEC Form 10-Q filed by Avanos Medical Inc.

      10-Q - AVANOS MEDICAL, INC. (0001606498) (Filer)

      5/6/25 4:17:36 PM ET
      $AVNS
      Industrial Specialties
      Health Care

    $AVNS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Former Interim CEO Greiner Michael covered exercise/tax liability with 24,245 shares, decreasing direct ownership by 11% to 200,019 units (SEC Form 4)

      4 - AVANOS MEDICAL, INC. (0001606498) (Issuer)

      5/14/25 2:28:49 PM ET
      $AVNS
      Industrial Specialties
      Health Care
    • New insider Pickett Jason Marc claimed ownership of 40,113 shares (SEC Form 3)

      3 - AVANOS MEDICAL, INC. (0001606498) (Issuer)

      4/29/25 3:45:04 PM ET
      $AVNS
      Industrial Specialties
      Health Care
    • Amendment: New insider Pacitti David claimed ownership of 242,047 shares (SEC Form 3)

      3/A - AVANOS MEDICAL, INC. (0001606498) (Issuer)

      4/24/25 5:00:37 PM ET
      $AVNS
      Industrial Specialties
      Health Care

    $AVNS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Avanos Medical downgraded by KeyBanc Capital Markets

      KeyBanc Capital Markets downgraded Avanos Medical from Overweight to Sector Weight

      7/25/23 6:15:12 AM ET
      $AVNS
      Industrial Specialties
      Health Care
    • CL King initiated coverage on Avanos Medical with a new price target

      CL King initiated coverage of Avanos Medical with a rating of Buy and set a new price target of $31.00

      5/22/23 8:52:10 AM ET
      $AVNS
      Industrial Specialties
      Health Care
    • Keybanc reiterated coverage on Avanos Medical with a new price target

      Keybanc reiterated coverage of Avanos Medical with a rating of Overweight and set a new price target of $41.00 from $47.00 previously

      2/24/22 4:48:01 AM ET
      $AVNS
      Industrial Specialties
      Health Care

    $AVNS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Avanos Medical, Inc. Welcomes Camille Chang Gilmore as Senior Vice President and Chief Human Resources Officer

      ALPHARETTA, Ga., June 9, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) a leading medical technology company focused on delivered innovative healthcare solutions, today announced the appointment of Camille Chang Gilmore as senior vice president and chief human resources officer. In this role, Gilmore will lead all aspects of Avanos' people strategy, including talent acquisition and development, workforce planning, leadership development and employee experience. Her arrival reflects the company's continued commitment to building a workplace where every employee feels val

      6/9/25 7:15:00 AM ET
      $AVNS
      Industrial Specialties
      Health Care
    • Avanos Medical, Inc. Announces First Quarter 2025 Results

      ALPHARETTA, Ga., May 6, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) today reported first quarter 2025 financial results. "In my first couple of weeks at Avanos, I've noticed that the transformation efforts made around the portfolio, the organizational structure and cost management have positioned us well to accelerate our growth profile," said David Pacitti, Avanos's recently appointed Chief Executive Officer. Pacitti continued, "I really like the energy and strategic focus we have right now, which can be leveraged for more consistent execution, to identify more go-t

      5/6/25 7:00:00 AM ET
      $AVNS
      Industrial Specialties
      Health Care
    • Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2025 Financial Results

      ALPHARETTA, Ga., April 28, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2025 on Tuesday, May 6 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Dave Pacitti, chief executive officer, Jason Pickett, interim chief financial officer, Scott Galovan, senior vice president, strategy and corporate development, and Gary Blackford, Avanos board chairman. To instantly jo

      4/28/25 7:47:00 AM ET
      $AVNS
      Industrial Specialties
      Health Care